| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |